查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946633

2026年全球核酸增幅检查市场报告

Nucleic Acid Amplification Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，核酸增幅检查市场发展迅速，预计将从2025年的110.3亿美元成长到2026年的127亿美元，复合年增长率达15.2%。过去几年成长要素包括感染疾病的爆发、临床检查室的扩张、PCR技术的广泛应用、公共卫生筛检计画的实施以及检测成本的下降。

预计未来几年核酸增幅检查市场将快速成长，到2030年市场规模将达221亿美元，复合年增长率（CAGR）为14.8%。预测期内的成长要素包括个人化医疗的进步、对快速诊断的需求、新兴市场的扩张、技术的微型化以及新型检测方法的监管核准。预测期内的主要趋势包括快速照护现场分子检测、多重和综合征检测方案的扩展、等温扩增技术的日益普及、居家和分散式检查的增长以及对疾病早期检测的日益重视。

感染疾病率的不断上升将进一步推动核酸增幅检查市场在未来的扩张。感染疾病是由病原体引起的疾病，其传播途径包括直接接触、空气传播、受污染的食物和水以及媒介传播。感染疾病的增加与抗生素抗药性、气候变迁、人类行为的改变以及农业实践的改变密切相关。核酸增幅检查能够快速且准确地识别感染疾病病原体，从而支持及时诊断和治疗，并有助于控制疾病传播。例如，根据加拿大公共卫生署（一个政府机构）2023年10月发布的公告，参与的省份和地区在2022-2023流感季报告了4216例与流感相关的住院病例。因此，感染疾病率的不断上升正在增强对核酸增幅检查解决方案的需求。

核酸增幅检查市场的主要企业正致力于开发创新解决方案，例如体外诊断 (IVD) 检测。例如，IVD 检测采用符合体外诊断药物法规 (IVDR) 的核酸扩增技术 (NAT) 对捐血血液中的巨细胞病毒(CMV) 进行筛检。 IVD 检测是在实验室对生物检体的检测，用于检测人体以外的疾病、病症或感染疾病。例如，总部位于德国的 GFE 公司于 2024 年 6 月推出了“PoET CMV”，这是一种用于快速、准确检测 CMV 感染的 IVD 检测方法。此检测方法具有高灵敏度和特异性，可支持对移植患者和免疫力缺乏患者进行 CMV 的早期诊断和有效监测。透过利用先进的分子技术，此检测方法可提供快速、可靠的结果，从而支援及时的临床决策。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球核酸增幅检查市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 快速照护现场分子检测
    • 扩大多重和综合征检测小组
    • 等温扩增技术的应用日益广泛
    • 居家检测和分散式检查的成长
    • 人们越来越关注疾病早期检测

第五章 终端用户产业市场分析

  • 医院
  • 诊断检查室
  • 生技公司
  • 研究所
  • 公共卫生机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球核酸增幅检查市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球核酸增幅检查市场规模、对比及成长率分析
  • 全球核酸增幅检查市场表现：规模与成长，2020-2025年
  • 全球核酸增幅检查市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 标靶放大系统、探针放大系统、讯号放大系统
  • 透过扩增方法
  • 耗材、设备或系统
  • 透过技术
  • 聚合酵素链锁反应（PCR）检测、恒温核酸增幅技术（INAAT）检测与连接酶炼式反应（LCR）检测
  • 透过使用
  • 传染病检查、肿瘤检测、遗传和粒线体疾病检测以及其他应用
  • 按最终用途
  • 医院、诊断检查室、生物技术公司和其他终端用户
  • 按类型细分：标靶扩增系统
  • 聚合酵素链锁反应（PCR）、即时PCR（qPCR）、逆转录聚合酵素链锁反应（RT-PCR）、巢式PCR、多重PCR、恒温环型核酸扩增（LAMP）
  • 按类型细分：探针放大系统
  • 核酸序列扩增（NASBA）、杂合反应扩增、支链扩增（BCA）、链置换扩增（SDA）
  • 按类型细分：讯号放大系统
  • 酵素讯号放大、萤光讯号放大、化学冷光讯号放大、电化学讯号放大、磁性颗粒讯号放大

第十章 区域与国家分析

  • 全球核酸增幅检查市场：依地区划分，结果及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球核酸增幅检查市场：依国家/地区、效能和预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 核酸增幅检查市场：竞争格局及市场占有率（2024年）
  • 核酸增幅检查市场：公司评估矩阵
  • 核酸增幅检查市场：公司概况
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Merck KGaA
    • Siemens Healthineers

第37章：其他领先和创新企业

  • Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols SA, Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年核酸增幅检查市场：提供新机会的国家
  • 核酸增幅检查市场展望（2030）：新兴细分市场蕴藏新的机会
  • 核酸增幅检查市场2030年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MNAAT02_G26Q1

Nucleic acid amplification testing (NAAT) is a molecular technique that detects and amplifies DNA or RNA in samples, enabling early pathogen detection and advancing research into genetic diseases and targeted therapies.

The primary types of nucleic acid amplification testing include target amplification systems, probe amplification systems, and signal amplification systems. Target amplification systems are methods used to amplify specific nucleic acid sequences within a sample and are essential for improving sensitivity and precision in nucleic acid amplification testing (NAAT). The product categories include consumables and instruments or systems incorporating technologies such as polymerase chain reaction (PCR) tests, isothermal nucleic acid amplification technology (INAAT) tests, and ligase chain reaction (LCR) tests. These are applied in areas including infectious disease testing, oncology diagnostics, genetic and mitochondrial disease testing, and others and are used by end users such as hospitals, diagnostic laboratories, biotechnology companies, and others.

Tariffs are impacting the nucleic acid amplification testing market by increasing costs of imported reagents, instruments, and precision components used in PCR and isothermal systems. Consumables and instruments segments are most affected, particularly in Asia-Pacific and North America where global supply chains are highly interconnected. Higher costs have slowed procurement cycles for hospitals and diagnostic laboratories. However, tariffs are encouraging local manufacturing, regional sourcing, and domestic capacity expansion, supporting long-term supply chain resilience.

The nucleic acid amplification testing market research report is one of a series of new reports from The Business Research Company that provides nucleic acid amplification testing market statistics, including nucleic acid amplification testing industry global market size, regional shares, competitors with a nucleic acid amplification testing market share, detailed nucleic acid amplification testing market segments, market trends and opportunities, and any further data you may need to thrive in the nucleic acid amplification testing industry. This nucleic acid amplification testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nucleic acid amplification testing market size has grown rapidly in recent years. It will grow from $11.03 billion in 2025 to $12.7 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to infectious disease outbreaks, expansion of clinical laboratories, PCR technology adoption, public health screening programs, declining assay costs.

The nucleic acid amplification testing market size is expected to see rapid growth in the next few years. It will grow to $22.1 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to personalized medicine growth, demand for rapid diagnostics, expansion in emerging markets, technological miniaturization, regulatory approvals for novel assays. Major trends in the forecast period include rapid point-of-care molecular testing, expansion of multiplex and syndromic panels, rising adoption of isothermal amplification techniques, growth in home-based and decentralized testing, increasing focus on early disease detection.

The increasing incidence of infectious diseases is increasingly supporting the expansion of the nucleic acid amplification testing market going forward. Infectious diseases are conditions caused by pathogenic organisms that spread through direct contact, airborne transmission, contaminated food or water, or vector-borne pathways. The rise in infectious diseases is associated with antibiotic resistance, climate change, changes in human behavior, and agricultural practices. Nucleic acid amplification testing enables rapid and accurate identification of infectious pathogens, supporting timely diagnosis and treatment while helping limit disease transmission. For example, in October 2023, according to the Public Health Agency of Canada, a government agency, participating provinces and territories reported 4,216 influenza-related hospitalizations during the 2022-2023 season. Consequently, the growing incidence of infectious diseases is strengthening demand for nucleic acid amplification testing solutions.

Leading companies operating in the nucleic acid amplification testing market are focusing on developing innovative solutions, such as in vitro diagnostics (IVD) assays, to screen donated blood for cytomegalovirus (CMV) using nucleic acid amplification technology (NAT) in compliance with the IVDR. An IVD assay is a laboratory-based test performed on biological samples to detect diseases, conditions, or infections outside the human body. For example, in June 2024, GFE, a Germany-based company, launched PoET CMV, an IVD assay designed for the rapid and accurate detection of CMV infections. The assay offers high sensitivity and specificity, supporting early diagnosis and effective monitoring of CMV in transplant recipients and immunocompromised patients. By leveraging advanced molecular techniques, the test delivers reliable results quickly, enabling timely clinical decision-making.

In July 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, acquired LumiraDx for an undisclosed amount. With this acquisition, Roche aims to expand its diagnostics division by offering a broader range of immunoassay and clinical chemistry tests that provide high-value testing without requiring specialized cold storage. This approach supports use across diverse healthcare settings while improving testing efficiency and patient outcomes, particularly in primary care and underserved regions. LumiraDx is a UK-based provider of nucleic acid amplification testing solutions.

Major companies operating in the nucleic acid amplification testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Eiken Chemical Co. Ltd., New England Biolabs Inc., TwistDx Limited, Bioneer Corporation

North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nucleic acid amplification testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The nucleic acid amplification testing (NAAT) market consists of revenue earned by entities by provide services such as genetic disorder screening, environmental testing, infectious disease diagnosis, and pharmacogenomics. The market value includes the value of related goods sold by the service provider or included within the service offering. The nucleic acid amplification testing (NAAT) market also includes sales of reagents, pre-packaged kits, test tubes, pipettes, and plates. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nucleic Acid Amplification Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses nucleic acid amplification testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nucleic acid amplification testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nucleic acid amplification testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Target Amplification Systems; Probe Amplification Systems; Signal Amplification Systems
  • 2) By Amplification Method: Consumables; Instruments Or Systems
  • 3) By Technology: Polymerase Chain Reaction (PCR) Tests; Isothermal Nucleic Acid Amplification Technology (INAAT) Tests; Ligase Chain Reaction (LCR) Tests
  • 4) By Application: Infectious Disease Testing; Oncology Testing; Genetic And Mitochondrial Disease Testing; Other Applications
  • 5) By End-Use: Hospitals; Diagnostic Laboratories; Biotechnology Companies; Other End-Users
  • Subsegments:
  • 1) By Target Amplification Systems: Polymerase Chain Reaction (PCR); Real-Time PCR (qPCR); Reverse Transcription PCR (RT-PCR); Nested PCR; Multiplex PCR; LAMP (Loop-Mediated Isothermal Amplification);
  • 2) By Probe Amplification Systems: Nucleic Acid Sequence-Based Amplification (NASBA); Hybridization-Based Amplification; Branch Chain Amplification (BCA); Strand Displacement Amplification (SDA);
  • 3) By Signal Amplification Systems: Enzyme-Linked Signal Amplification; Fluorescent Signal Amplification; Chemiluminescent Signal Amplification; Electrochemical Signal Amplification; Magnetic Particle-Based Signal Amplification
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA; Siemens Healthineers; Becton Dickinson and Company; Laboratory Corporation of America Holdings; Quest Diagnostics; Agilent Technologies Inc.; Grifols S.A.; Hologic Inc.; bioMerieux SA; QuidelOrtho Corporation; Bio-Rad Laboratories Inc.; Cepheid Inc.; GenScript Biotech Corporation; ARUP Laboratories; BGI Group; Promega Corporation; Meridian Bioscience Inc.; Takara Bio Inc.; Eiken Chemical Co. Ltd.; New England Biolabs Inc.; TwistDx Limited; Bioneer Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Nucleic Acid Amplification Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Nucleic Acid Amplification Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Nucleic Acid Amplification Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Nucleic Acid Amplification Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rapid Point-Of-Care Molecular Testing
    • 4.2.2 Expansion Of Multiplex And Syndromic Panels
    • 4.2.3 Rising Adoption Of Isothermal Amplification Techniques
    • 4.2.4 Growth In Home-Based And Decentralized Testing
    • 4.2.5 Increasing Focus On Early Disease Detection

5. Nucleic Acid Amplification Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Biotechnology Companies
  • 5.4 Research Institutes
  • 5.5 Public Health Agencies

6. Nucleic Acid Amplification Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nucleic Acid Amplification Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Nucleic Acid Amplification Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Nucleic Acid Amplification Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Nucleic Acid Amplification Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Nucleic Acid Amplification Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nucleic Acid Amplification Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nucleic Acid Amplification Testing Market Segmentation

  • 9.1. Global Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems
  • 9.2. Global Nucleic Acid Amplification Testing Market, Segmentation By Amplification Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consumables, Instruments Or Systems
  • 9.3. Global Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests
  • 9.4. Global Nucleic Acid Amplification Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infectious Disease Testing, Oncology Testing, Genetic And Mitochondrial Disease Testing, Other Applications
  • 9.5. Global Nucleic Acid Amplification Testing Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Laboratories, Biotechnology Companies, Other End-Users
  • 9.6. Global Nucleic Acid Amplification Testing Market, Sub-Segmentation Of Target Amplification Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Nested PCR, Multiplex PCR, LAMP (Loop-Mediated Isothermal Amplification)
  • 9.7. Global Nucleic Acid Amplification Testing Market, Sub-Segmentation Of Probe Amplification Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Nucleic Acid Sequence-Based Amplification (NASBA), Hybridization-Based Amplification, Branch Chain Amplification (BCA), Strand Displacement Amplification (SDA)
  • 9.8. Global Nucleic Acid Amplification Testing Market, Sub-Segmentation Of Signal Amplification Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Signal Amplification, Fluorescent Signal Amplification, Chemiluminescent Signal Amplification, Electrochemical Signal Amplification, Magnetic Particle-Based Signal Amplification

10. Nucleic Acid Amplification Testing Market Regional And Country Analysis

  • 10.1. Global Nucleic Acid Amplification Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Nucleic Acid Amplification Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nucleic Acid Amplification Testing Market

  • 11.1. Asia-Pacific Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nucleic Acid Amplification Testing Market

  • 12.1. China Nucleic Acid Amplification Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nucleic Acid Amplification Testing Market

  • 13.1. India Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nucleic Acid Amplification Testing Market

  • 14.1. Japan Nucleic Acid Amplification Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nucleic Acid Amplification Testing Market

  • 15.1. Australia Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Nucleic Acid Amplification Testing Market

  • 16.1. Indonesia Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Nucleic Acid Amplification Testing Market

  • 17.1. South Korea Nucleic Acid Amplification Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Nucleic Acid Amplification Testing Market

  • 18.1. Taiwan Nucleic Acid Amplification Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Nucleic Acid Amplification Testing Market

  • 19.1. South East Asia Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Nucleic Acid Amplification Testing Market

  • 20.1. Western Europe Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Nucleic Acid Amplification Testing Market

  • 21.1. UK Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Nucleic Acid Amplification Testing Market

  • 22.1. Germany Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Nucleic Acid Amplification Testing Market

  • 23.1. France Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Nucleic Acid Amplification Testing Market

  • 24.1. Italy Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Nucleic Acid Amplification Testing Market

  • 25.1. Spain Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Nucleic Acid Amplification Testing Market

  • 26.1. Eastern Europe Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Nucleic Acid Amplification Testing Market

  • 27.1. Russia Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Nucleic Acid Amplification Testing Market

  • 28.1. North America Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Nucleic Acid Amplification Testing Market

  • 29.1. USA Nucleic Acid Amplification Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Nucleic Acid Amplification Testing Market

  • 30.1. Canada Nucleic Acid Amplification Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Nucleic Acid Amplification Testing Market

  • 31.1. South America Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Nucleic Acid Amplification Testing Market

  • 32.1. Brazil Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Nucleic Acid Amplification Testing Market

  • 33.1. Middle East Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Nucleic Acid Amplification Testing Market

  • 34.1. Africa Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Nucleic Acid Amplification Testing Market Regulatory and Investment Landscape

36. Nucleic Acid Amplification Testing Market Competitive Landscape And Company Profiles

  • 36.1. Nucleic Acid Amplification Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Nucleic Acid Amplification Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Nucleic Acid Amplification Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

37. Nucleic Acid Amplification Testing Market Other Major And Innovative Companies

  • Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc.

38. Global Nucleic Acid Amplification Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Nucleic Acid Amplification Testing Market

40. Nucleic Acid Amplification Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Nucleic Acid Amplification Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Nucleic Acid Amplification Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Nucleic Acid Amplification Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer